We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Date
Sponsor content
2 result(s) found, displaying 1 to 2
-
Prescription medicine decision summaryTGA Decision: Bimzelx (bimekizumab) is approved to treat moderate to severe plaque psoriasis in adult patients.
-
Prescription medicine registrationActive ingredients: bimekizumab.